Top Ten most popular articles on Pharmafile.com this week
pharmafile | August 28, 2020 | News story | Medical Communications |Â Â COVID-19, Vaccine, coronavirus vaccine, top 10Â
The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move ahead with human testing of a potential vaccine that has been created using insect cells, while AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus.
In other news, the FDA has approved a request from American Gene Technologies to begin a clinical study of its HIV gene therapy and a 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19.
1. Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests
Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company.
2. AstraZeneca begins antibody COVID-19 treatment trial in the UK
AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus.
3. China’s ‘insect’ vaccine for COVID-19 approved for human testing
China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells.
4. FDA approves Phase 1 trial for HIV gene therapy
The FDA has approved a request from American Gene Technologies to begin a clinical study into its HIV gene therapy.
5. Thousands of coronavirus cases recorded in hospital were caught on site, new research suggests
Thousands of coronavirus cases are thought to have been transmitted within UK hospitals, according to a new study.
6. Gilead says FDA could expand eligibility of coronavirus patients for remdesivir
The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.
AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases.
8. FDA approves Novartis’ MS drug Kesimpta for treating relapsed forms of the disease
The FDA has authorised Novartis’ Kesimpta (ofatumumab) for treating patients with relapsing forms of multiple sclerosis (MS), it has been revealed.
9. 75-year-old Nottinghamshire woman may be first known British victim of coronavirus
A 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19.
10. AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and either carboplatin or cisplatin platinum chemotherapy, it has emerged.
Related Content
BioNet receives positive EMA opinion on new pertussis vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use …
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
